A citation-based method for searching scientific literature

Navya Nair, Cecelia Bellcross, Lisa Haddad, Monique Martin, Roland Matthews, Sheryl Gabram-Mendola, Barbara Crane, Dana Meaney-Delman. J Cancer Educ 2017
Times Cited: 7







List of co-cited articles
42 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


A statewide survey of practitioners to assess knowledge and clinical practices regarding hereditary breast and ovarian cancer.
Tuya Pal, Deborah Cragun, Courtney Lewis, Andrea Doty, Maria Rodriguez, Cristi Radford, Zachary Thompson, Jongphil Kim, Susan T Vadaparampil. Genet Test Mol Biomarkers 2013
40
42


Prevalence and healthcare actions of women in a large health system with a family history meeting the 2005 USPSTF recommendation for BRCA genetic counseling referral.
Cecelia A Bellcross, Steven Leadbetter, Sharon Hensley Alford, Lucy A Peipins. Cancer Epidemiol Biomarkers Prev 2013
41
42

Awareness and utilization of BRCA1/2 testing among U.S. primary care physicians.
Cecelia A Bellcross, Katherine Kolor, Katrina A B Goddard, Ralph J Coates, Michele Reyes, Muin J Khoury. Am J Prev Med 2011
111
42



Expanding access to BRCA1/2 genetic counseling with telephone delivery: a cluster randomized trial.
Anita Y Kinney, Karin M Butler, Marc D Schwartz, Jeanne S Mandelblatt, Kenneth M Boucher, Lisa M Pappas, Amanda Gammon, Wendy Kohlmann, Sandra L Edwards, Antoinette M Stroup,[...]. J Natl Cancer Inst 2014
73
28

Randomized noninferiority trial of telephone versus in-person genetic counseling for hereditary breast and ovarian cancer.
Marc D Schwartz, Heiddis B Valdimarsdottir, Beth N Peshkin, Jeanne Mandelblatt, Rachel Nusbaum, An-Tsun Huang, Yaojen Chang, Kristi Graves, Claudine Isaacs, Marie Wood,[...]. J Clin Oncol 2014
148
28


BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases.
Tuya Pal, Jenny Permuth-Wey, Judith A Betts, Jeffrey P Krischer, James Fiorica, Hector Arango, James LaPolla, Mitchell Hoffman, Martin A Martino, Katie Wakeley,[...]. Cancer 2005
491
28

American Society of Clinical Oncology Expert Statement: collection and use of a cancer family history for oncology providers.
Karen H Lu, Marie E Wood, Molly Daniels, Cathy Burke, James Ford, Noah D Kauff, Wendy Kohlmann, Noralane M Lindor, Therese M Mulvey, Linda Robinson,[...]. J Clin Oncol 2014
138
28




Uptake rates for breast cancer genetic testing: a systematic review.
Mary E Ropka, Jennifer Wenzel, Elayne K Phillips, Mir Siadaty, John T Philbrick. Cancer Epidemiol Biomarkers Prev 2006
112
28

Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study Group.
S A Narod, J S Brunet, P Ghadirian, M Robson, K Heimdal, S L Neuhausen, D Stoppa-Lyonnet, C Lerman, B Pasini, P de los Rios,[...]. Lancet 2000
383
28

"Many miles to go …": a systematic review of the implementation of patient decision support interventions into routine clinical practice.
Glyn Elwyn, Isabelle Scholl, Caroline Tietbohl, Mala Mann, Adrian G K Edwards, Catharine Clay, France Légaré, Trudy van der Weijden, Carmen L Lewis, Richard M Wexler,[...]. BMC Med Inform Decis Mak 2013
257
28

Recent Enhancements to the Genetic Risk Prediction Model BRCAPRO.
Emanuele Mazzola, Amanda Blackford, Giovanni Parmigiani, Swati Biswas. Cancer Inform 2015
19
28

American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography.
Debbie Saslow, Carla Boetes, Wylie Burke, Steven Harms, Martin O Leach, Constance D Lehman, Elizabeth Morris, Etta Pisano, Mitchell Schnall, Stephen Sener,[...]. CA Cancer J Clin 2007
28

The 9-item Shared Decision Making Questionnaire (SDM-Q-9). Development and psychometric properties in a primary care sample.
Levente Kriston, Isabelle Scholl, Lars Hölzel, Daniela Simon, Andreas Loh, Martin Härter. Patient Educ Couns 2010
309
28

Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.
Susan M Domchek, Tara M Friebel, Christian F Singer, D Gareth Evans, Henry T Lynch, Claudine Isaacs, Judy E Garber, Susan L Neuhausen, Ellen Matloff, Rosalind Eeles,[...]. JAMA 2010
824
28

Barriers and Facilitators to Patient-Provider Communication When Discussing Breast Cancer Risk to Aid in the Development of Decision Support Tools.
Haeseung Yi, Tong Xiao, Parijatham S Thomas, Alejandra N Aguirre, Cindy Smalletz, Jill Dimond, Joseph Finkelstein, Katherine Infante, Meghna Trivedi, Raven David,[...]. AMIA Annu Symp Proc 2015
11
28

Effect of arrangement of stick figures on estimates of proportion in risk graphics.
Jessica S Ancker, Elke U Weber, Rita Kukafka. Med Decis Making 2011
18
28

Usability Testing of a Web-Based Decision Aid for Breast Cancer Risk Assessment Among Multi-Ethnic Women.
Austin M Coe, William Ueng, Jennifer M Vargas, Raven David, Alejandro Vanegas, Katherine Infante, Meghna Trivedi, Haeseung Yi, Jill Dimond, Katherine D Crew,[...]. AMIA Annu Symp Proc 2017
10
28

Efficient identification and referral of low-income women at high risk for hereditary breast cancer: a practice-based approach.
G Joseph, C Kaplan, J Luce, R Lee, S Stewart, C Guerra, R Pasick. Public Health Genomics 2012
18
28

Breast cancer risk communication: assessment of primary care physicians by standardized patients.
Julie O Culver, Deborah J Bowen, Susan E Reynolds, Linda E Pinsky, Nancy Press, Wylie Burke. Genet Med 2009
18
28

Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.
Karoline B Kuchenbaecker, John L Hopper, Daniel R Barnes, Kelly-Anne Phillips, Thea M Mooij, Marie-José Roos-Blom, Sarah Jervis, Flora E van Leeuwen, Roger L Milne, Nadine Andrieu,[...]. JAMA 2017
783
28

Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study.
Susan M Domchek, Tara M Friebel, Susan L Neuhausen, Theresa Wagner, Gareth Evans, Claudine Isaacs, Judy E Garber, Mary B Daly, Rosalind Eeles, Ellen Matloff,[...]. Lancet Oncol 2006
210
28


Decision aids for people facing health treatment or screening decisions.
A M O'Connor, D Stacey, V Entwistle, H Llewellyn-Thomas, D Rovner, M Holmes-Rovner, V Tait, J Tetroe, V Fiset, M Barry,[...]. Cochrane Database Syst Rev 2003
330
28

The comprehensiveness of family cancer history assessments in primary care.
Harvey J Murff, Robert A Greevy, Sapna Syngal. Community Genet 2007
75
28


Prospective study of breast cancer incidence in women with a BRCA1 or BRCA2 mutation under surveillance with and without magnetic resonance imaging.
Ellen Warner, Kimberley Hill, Petrina Causer, Donald Plewes, Roberta Jong, Martin Yaffe, William D Foulkes, Parviz Ghadirian, Henry Lynch, Fergus Couch,[...]. J Clin Oncol 2011
154
28


A measure of informed choice.
T M Marteau, E Dormandy, S Michie. Health Expect 2001
436
28

BRCA1 and BRCA2 genetic testing in Hispanic patients: mutation prevalence and evaluation of the BRCAPRO risk assessment model.
Kristen J Vogel, Deann P Atchley, Julie Erlichman, Kristine R Broglio, Kaylene J Ready, Vicente Valero, Christopher I Amos, Gabriel N Hortobagyi, Karen H Lu, Banu Arun. J Clin Oncol 2007
46
28

Prophylactic mastectomy in BRCA1 and BRCA2 mutation carriers: very low risk for subsequent breast cancer.
Reinoutje Kaas, Senno Verhoef, Jelle Wesseling, Matti A Rookus, Hester S A Oldenburg, Marie-Jeanne Vrancken Peeters, Emiel J T Rutgers. Ann Surg 2010
51
28

Systematic review: using magnetic resonance imaging to screen women at high risk for breast cancer.
Ellen Warner, Hans Messersmith, Petrina Causer, Andrea Eisen, Rene Shumak, Donald Plewes. Ann Intern Med 2008
321
28

Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study.
Noah D Kauff, Susan M Domchek, Tara M Friebel, Mark E Robson, Johanna Lee, Judy E Garber, Claudine Isaacs, D Gareth Evans, Henry Lynch, Rosalind A Eeles,[...]. J Clin Oncol 2008
348
28

Why Breast Cancer Risk by the Numbers Is Not Enough: Evaluation of a Decision Aid in Multi-Ethnic, Low-Numerate Women.
Rita Kukafka, Haeseung Yi, Tong Xiao, Parijatham Thomas, Alejandra Aguirre, Cindy Smalletz, Raven David, Katherine Crew. J Med Internet Res 2015
20
28

Reported referral for genetic counseling or BRCA 1/2 testing among United States physicians: a vignette-based study.
Katrina F Trivers, Laura-Mae Baldwin, Jacqueline W Miller, Barbara Matthews, C Holly A Andrilla, Denise M Lishner, Barbara A Goff. Cancer 2011
76
28

Impact of oophorectomy on cancer incidence and mortality in women with a BRCA1 or BRCA2 mutation.
Amy P M Finch, Jan Lubinski, Pål Møller, Christian F Singer, Beth Karlan, Leigha Senter, Barry Rosen, Lovise Maehle, Parviz Ghadirian, Cezary Cybulski,[...]. J Clin Oncol 2014
328
28

Awareness of cancer susceptibility genetic testing: the 2000, 2005, and 2010 National Health Interview Surveys.
Phuong L Mai, Susan Thomas Vadaparampil, Nancy Breen, Timothy S McNeel, Louise Wideroff, Barry I Graubard. Am J Prev Med 2014
69
14


The role of genome sequencing in personalized breast cancer prevention.
Weiva Sieh, Joseph H Rothstein, Valerie McGuire, Alice S Whittemore. Cancer Epidemiol Biomarkers Prev 2014
9
14

Educational needs and preferred methods of learning among Florida practitioners who order genetic testing for hereditary breast and ovarian cancer.
Deborah Cragun, Andrea Doty Besharat, Courtney Lewis, Susan T Vadaparampil, Tuya Pal. J Cancer Educ 2013
12
14


Hereditary cancer predisposition syndromes.
Judy E Garber, Kenneth Offit. J Clin Oncol 2005
320
14

Screening for colorectal cancer: a targeted, updated systematic review for the U.S. Preventive Services Task Force.
Evelyn P Whitlock, Jennifer S Lin, Elizabeth Liles, Tracy L Beil, Rongwei Fu. Ann Intern Med 2008
551
14

Direct-to-consumer personalized genomic testing.
Cinnamon S Bloss, Burcu F Darst, Eric J Topol, Nicholas J Schork. Hum Mol Genet 2011
60
14


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.